Arrowhead Pharmaceuticals

Arrowhead targets rare disease patients with awareness campaign

Arrowhead is laying the groundwork for its entry into a rare disease market, kicking off an awareness campaign focused on a need its drug could serve.

Nick Paul Taylor Nov 5, 2024 11:58am

Arrowhead's plozasiran could reach $700M-plus in sales: report

Apr 16, 2024 3:05pm

Illustration connected puzzle pieces with the acronym MA

Alnylam, Intra-Cellular among RBC's top picks for M&A

Apr 19, 2023 3:20pm